Copyright © 2012 Philip Y. Lam and Kam Ming Ko. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. M. F. Beal, “Mitochondria, free radicals, and neurodegeneration,” Current Opinion in Neurobiology, vol. 6, no. 5, pp. 661–666, 1996. View at Publisher · View at Google Scholar · View at Scopus
2. A. C. Bowling and M. F. Beal, “Bioenergetic and oxidative stress in neurodegenerative diseases,” Life Sciences, vol. 56, no. 14, pp. 1151–1171, 1995. View at Publisher · View at Google Scholar · View at Scopus
3. P. Y. Lam, F. Yin, R. T. Hamilton, A. Boveris, and E. Cadenas, “Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production,” Free Radical Research, vol. 43, no. 5, pp. 431–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
4. M. P. Mattson and T. Magnus, “Ageing and neuronal vulnerability,” Nature Reviews Neuroscience, vol. 7, no. 4, pp. 278–294, 2006. View at Publisher · View at Google Scholar · View at Scopus
5. G. S. Watson and S. Craft, “The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment,” Central Nervous System Drugs, vol. 17, no. 1, pp. 27–45, 2003. View at Publisher · View at Google Scholar · View at Scopus
6. A. Y. Abramov, M. Gegg, A. Grunewald, N. W. Wood, C. Klein, and A. H. Schapira, “Bioenergetic consequences of PINK1 mutations in Parkinson disease,” PLoS One, vol. 6, no. 10, Article ID e25622, 2011.
7. R. Nogueiras, M. H. Tschop, and J. M. Zigman, “Central nervous system regulation of energy metabolism: ghrelin versus leptin,” Annals of the New York Academy of Sciences, vol. 1126, pp. 14–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
8. D. C. Wallace, “Mitochondrial DNA in aging and disease,” Scientific American, vol. 277, no. 2, pp. 40–47, 1997. View at Scopus
9. E. Cadenas, “Mitochondrial free radical production and cell signaling,” Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 17–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
10. P. Storz, “Reactive oxygen species-mediated mitochondria-to-nucleus signaling: a key to aging and radical-caused diseases,” Science's STKE, vol. 2006, no. 332, article re3, 2006. View at Publisher · View at Google Scholar · View at Scopus
11. M. F. Beal, “Aging, energy, and oxidative stress in neurodegenerative diseases,” Annals of Neurology, vol. 38, no. 3, pp. 357–366, 1995. View at Publisher · View at Google Scholar · View at Scopus
12. M. F. Beal, “Energy, oxidative damage, and Alzheimer's disease: clues to the underlying puzzle,” Neurobiology of Aging, vol. 15, supplement 2, pp. S171–S174, 1994. View at Scopus
13. W. D. Parker Jr., S. J. Boyson, and J. K. Parks, “Abnormalities of the electron transport chain in idiopathic Parkinson's disease,” Annals of Neurology, vol. 26, no. 6, pp. 719–723, 1989. View at Publisher · View at Google Scholar · View at Scopus
14. W. D. Parker Jr., C. M. Filley, and J. K. Parks, “Cytochrome oxidase deficiency in Alzheimer's disease,” Neurology, vol. 40, no. 8, pp. 1302–1303, 1990. View at Scopus
15. W. D. Parker Jr., J. Parks, C. M. Filley, and B. K. Kleinschmidt-DeMasters, “Electron transport chain defects in Alzheimer's disease brain,” Neurology, vol. 44, no. 6, pp. 1090–1096, 1994. View at Scopus
16. S. Bharath and J. K. Andersen, “Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease,” Antioxidants and Redox Signaling, vol. 7, no. 7-8, pp. 900–910, 2005. View at Publisher · View at Google Scholar · View at Scopus
17. S. L. Marklund, N. G. Westman, E. Lundgren, and G. Roos, “Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues,” Cancer Research, vol. 42, no. 5, pp. 1955–1961, 1982. View at Scopus
18. S. Hussain, W. Slikker Jr., and S. F. Ali, “Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain,” International Journal of Developmental Neuroscience, vol. 13, no. 8, pp. 811–817, 1995. View at Publisher · View at Google Scholar · View at Scopus
19. A. Terman, T. Kurz, M. Navratil, E. A. Arriaga, and U. T. Brunk, “Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging,” Antioxidants and Redox Signaling, vol. 12, no. 4, pp. 503–535, 2010.
20. P. Klatt and S. Lamas, “Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress,” European Journal of Biochemistry, vol. 267, no. 16, pp. 4928–4944, 2000. View at Publisher · View at Google Scholar · View at Scopus
21. P. Inarrea, H. Moini, D. Rettori, et al., “Redox activation of mitochondrial intermembrane space Cu,Zn-superoxide dismutase,” Biochemical Journal, vol. 387, part 1, pp. 203–209, 205.
22. J. M. Taylor, U. Ali, R. C. Iannello, P. Hertzog, and P. J. Crack, “Diminished Akt phosphorylation in neurons lacking glutathione peroxidase-1 (Gpx1) leads to increased susceptibility to oxidative stress-induced cell death,” Journal of Neurochemistry, vol. 92, no. 2, pp. 283–293, 2005. View at Publisher · View at Google Scholar · View at Scopus
23. Q. Zhou, P. Y. Lam, D. Han, and E. Cadenas, “c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons,” Journal of Neurochemistry, vol. 104, no. 2, pp. 325–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
24. F. Cai, F. Wang, F. K. Lin et al., “Redox modulation of long-term potentiation in the hippocampus via regulation of the glycogen synthase kinase-3β pathway,” Free Radical Biology and Medicine, vol. 45, no. 7, pp. 964–970, 2008. View at Publisher · View at Google Scholar · View at Scopus
25. D. Han, R. Canali, J. Garcia, R. Aguilera, T. K. Gallaher, and E. Cadenas, “Sites and mechanisms of aconitase inactivation by peroxynitrite: modulation by citrate and glutathione,” Biochemistry, vol. 44, no. 36, pp. 11986–11996, 2005. View at Publisher · View at Google Scholar · View at Scopus
26. S. Hoyer, “Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update,” Experimental Gerontology, vol. 35, no. 9-10, pp. 1363–1372, 2000. View at Publisher · View at Google Scholar · View at Scopus
27. A. J. Kowaltowski, R. F. Castilho, and A. E. Vercesi, “Mitochondrial permeability transition and oxidative stress,” The FEBS Letters, vol. 495, no. 1-2, pp. 12–15, 2001. View at Publisher · View at Google Scholar · View at Scopus
28. J. S. Kim, L. He, and J. J. Lemasters, “Mitochondrial permeability transition: a common pathway to necrosis and apoptosis,” Biochemical and Biophysical Research Communications, vol. 304, no. 3, pp. 463–470, 2003. View at Publisher · View at Google Scholar · View at Scopus
29. R. Jemmerson, J. M. Dubinsky, and N. Brustovetsky, “Cytochrome c release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases,” Antioxidants and Redox Signaling, vol. 7, no. 9-10, pp. 1158–1172, 2005. View at Publisher · View at Google Scholar · View at Scopus
30. K. M. Ko, D. H. F. Mak, P. Y. Chiu, and M. K. T. Poon, “Pharmacological basis of “Yang-invigoration” in Chinese medicine,” Trends in Pharmacological Sciences, vol. 25, no. 1, pp. 3–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
31. K. M. Ko and D. H. Mak, “Schisandrin B and other dibenzocyclooctadiene ligands,” in Herbal Medicine and Molecular Books in Health and Disease Management, P. Lester, C. Ong, and B. Halliwell, Eds., pp. 289–314, Marcel Dekker, New York, NY, USA, 2004.
32. N. Chen, P. Y. Chiu, and K. M. Ko, “Schisandrin B enhances cerebral mitochondrial antioxidant status and structural integrity, and protects against cerebral ischemia/reperfusion injury in rats,” Biological and Pharmaceutical Bulletin, vol. 31, no. 7, pp. 1387–1391, 2008. View at Publisher · View at Google Scholar · View at Scopus
33. P. Y. Lam, P. Y. Chiu, H. Y. Leung, N. Chen, P. K. Leong, and K. M. Ko, “Schisandrin B co-treatment ameliorates the impairment on mitochondrial antioxidant status in various tissues of long-term ethanol treated rats,” Fitoterapia, vol. 81, no. 8, pp. 1239–1245, 2010. View at Publisher · View at Google Scholar · View at Scopus
34. K. M. Ko and B. Y. H. Lam, “Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutathione antioxidant status in mouse brain,” Molecular and Cellular Biochemistry, vol. 238, no. 1-2, pp. 181–186, 2002. View at Publisher · View at Google Scholar · View at Scopus
35. V. V. Giridharan, R. A. Thandavarayan, H. N. Bhilwade, K. M. Ko, K. Watanabe, and T. Konishi, “Schisandrin B, attenuates cisplatin-induced oxidative stress genotoxicity and neurotoxicity through modulating NF-κB pathway in mice,” Free Radical Research, vol. 46, no. 1, pp. 50–60, 2012. View at Publisher · View at Google Scholar
36. V. V. Giridharan, R. A. Thandavarayan, S. Sato, K. M. Ko, and T. Konishi, “Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice,” Free Radical Research, vol. 45, no. 8, pp. 950–958, 2011. View at Publisher · View at Google Scholar · View at Scopus
37. K. M. Ko, N. Chen, H. Y. Leung, E. P. K. Leong, M. K. T. Poon, and P. Y. Chiu, “Long-term schisandrin B treatment mitigates age-related impairments in mitochondrial antioxidant status and functional ability in various tissues, and improves the survival of aging C57BL/6J mice,” BioFactors, vol. 34, no. 4, pp. 331–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
38. P. Y. Chiu, H. Y. Leung, M. K. T. Poon, and K. M. Ko, “Chronic schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middle-aged rats,” Biogerontology, vol. 7, no. 4, pp. 199–210, 2006. View at Publisher · View at Google Scholar · View at Scopus
39. J. P. Bolanos, A. Almeida, V. Stewart et al., “Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases,” Journal of Neurochemistry, vol. 68, no. 6, pp. 2227–2240, 1997. View at Scopus
40. O. A. Andreassen, R. J. Ferrante, A. Dedeoglu et al., “Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP,” Experimental Neurology, vol. 167, no. 1, pp. 189–195, 2001. View at Publisher · View at Google Scholar · View at Scopus
41. G. Guo, Y. Yan-Sanders, B. D. Lyn-Cook et al., “Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses,” Molecular and Cellular Biology, vol. 23, no. 7, pp. 2362–2378, 2003. View at Publisher · View at Google Scholar · View at Scopus
42. A. R. Hipkiss, “Energy metabolism, altered proteins, sirtuins and ageing: converging mechanisms?” Biogerontology, vol. 9, no. 1, pp. 49–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
43. T. F. Outeiro, O. Marques, and A. Kazantsev, “Therapeutic role of sirtuins in neurodegenerative disease,” Biochimica et Biophysica Acta, vol. 1782, no. 6, pp. 363–369, 2008. View at Publisher · View at Google Scholar · View at Scopus
44. M. C. Raff, A. V. Whitmore, and J. T. Finn, “Neuroscience: axonal self-destruction and neurodegeneration,” Science, vol. 296, no. 5569, pp. 868–871, 2002. View at Publisher · View at Google Scholar · View at Scopus
45. T. Araki, Y. Sasaki, and J. Milbrandt, “Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration,” Science, vol. 305, no. 5686, pp. 1010–1013, 2004. View at Publisher · View at Google Scholar · View at Scopus
46. D. J. Reed, “Glutathione: toxicological implications,” Annual Review of Pharmacology and Toxicology, vol. 30, pp. 603–631, 1990. View at Scopus
47. R. Mejias, J. Villadiego, C. O. Pintado, et al., “Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice,” The Journal of Neuroscience, vol. 26, no. 17, pp. 4500–4508, 2006.
48. L. S. Burwell and P. S. Brookes, “Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury,” Antioxidants and Redox Signaling, vol. 10, no. 3, pp. 579–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
49. C. M. Smith and M. Swash, “Possible biochemical basis of memory disorder in Alzheimer disease,” Annals of Neurology, vol. 3, no. 6, pp. 471–473, 1978. View at Scopus
50. Y. Y. Cui and M. Z. Wang, “Aspects of schizandrin metabolism in vitro and in vivo,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 18, no. 2, pp. 155–160, 1993. View at Scopus
51. R. L. Zheng, J. H. Kang, F. Y. Chen, P. F. Wang, J. G. Ren, and Q. L. Liu, “Difference in antioxidation for schisandrins and schisantherin between bio- and chemo-systems,” Phytotherapy Research, vol. 11, no. 8, pp. 600–602, 1997. View at Publisher · View at Google Scholar
52. L. Y. Lin, E. W. di Stefano, D. A. Schmitz et al., “Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6,” Drug Metabolism and Disposition, vol. 25, no. 9, pp. 1059–1064, 1997. View at Scopus
53. S. P. Ip, C. Y. Ma, C. T. Che, and K. M. Ko, “Methylenedioxy group as determinant of schisandrin in enhancing hepatic mitochondrial glutathione in carbon tetrachloride-intoxicated mice,” Biochemical Pharmacology, vol. 54, no. 2, pp. 317–319, 1997. View at Publisher · View at Google Scholar · View at Scopus
54. T. K. Yim and K. M. Ko, “Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione autioxidant status,” Molecular and Cellular Biochemistry, vol. 196, no. 1-2, pp. 151–156, 1999. View at Publisher · View at Google Scholar · View at Scopus
55. T. K. Yim and K. M. Ko, “Methylenedioxy group and cyclooctadiene ring as structural determinants of schisandrin in protecting against myocardial ischemia-reperfusion injury in rats,” Biochemical Pharmacology, vol. 57, no. 1, pp. 77–81, 1999. View at Publisher · View at Google Scholar · View at Scopus
56. P. Y. Lam and K. Ming Ko, “(-)Schisandrin B ameliorates paraquat-induced oxidative stress by suppressing glutathione depletion and enhancing glutathione recovery in differentiated PC12 cells,” BioFactors, vol. 37, no. 1, pp. 51–57, 2011. View at Publisher · View at Google Scholar · View at Scopus
57. P. Y. Lam, P. K. Leong, N. Chen, and K. M. Ko, “Schisandrin B enhances the glutathione redox cycling and protects against oxidant injury in different types of cultured cells,” BioFactors, vol. 37, no. 6, pp. 439–446, 2011.
58. A. C. Smith and M. R. Boyd, “Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity,” Journal of Pharmacology and Experimental Therapeutics, vol. 229, no. 3, pp. 658–663, 1984. View at Scopus
59. N. Doroshenko and P. Doroshenko, “Ion dependence of cytotoxicity of carmustine against PC12 cells,” European Journal of Pharmacology, vol. 476, no. 3, pp. 185–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
60. P. K. Leong, P. Y. Chiu, N. Chen, H. Leung, and K. M. Ko, “Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in AML12 hepatocytes,” Free Radical Research, vol. 45, no. 4, pp. 483–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
61. P. Y. Chiu, N. Chen, P. K. Leong, H. Y. Leung, and K. M. Ko, “Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in H9c2 cells,” Molecular and Cellular Biochemistry, vol. 350, no. 1-2, pp. 237–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
62. C. J. Weng, M. J. Chen, C. T. Yeh, and G. C. Yen, “Hepatoprotection of quercetin against oxidative stress by induction of metallothionein expression through activating MAPK and PI3K pathways and enhancing Nrf2 DNA-binding activity,” New Biotechnology, vol. 28, no. 6, pp. 767–777, 2011. View at Publisher · View at Google Scholar · View at Scopus
63. L. Troy, K. McFarland, S. Littman-Power, et al., “Cisplatin-based therapy: a neurological and neuropsychological review,” Psychooncology, vol. 9, no. 1, pp. 29–39, 2000.
64. V. Calabrese, C. Cornelius, A. T. Dinkova-Kostova, et al., “Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity,” Biochimica et Biophysica Acta, vol. 1822, no. 5, pp. 753–783, 2012. View at Publisher · View at Google Scholar
65. J. Kaiser, “Hormesis. Sipping from a poisoned chalice,” Science, vol. 302, no. 5644, pp. 376–379, 2003. View at Scopus
66. M. P. Mattson, “Hormesis defined,” Ageing Research Reviews, vol. 7, no. 1, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
67. E. J. Masoro, “Hormesis and the antiaging action of dietary restriction,” Experimental Gerontology, vol. 33, no. 1-2, pp. 61–66, 1998. View at Publisher · View at Google Scholar · View at Scopus
68. J. R. Cypser and T. E. Johnson, “Multiple stressors in Caenorhabditis elegans induce stress hormesis and extended longevity,” Journals of Gerontology Series A, vol. 57, no. 3, pp. B109–B114, 2002. View at Scopus
69. B. Conti, M. Sanchez-Alavez, R. Winsky-Sommerer et al., “Transgenic mice with a reduced core body temperature have an increased life span,” Science, vol. 314, no. 5800, pp. 825–828, 2006. View at Publisher · View at Google Scholar · View at Scopus
70. S. S. Ali, M. C. G. Marcondes, H. Bajova, L. L. Dugan, and B. Conti, “Metabolic depression and increased reactive oxygen species production by isolated mitochondria at moderately lower temperatures,” The Journal of Biological Chemistry, vol. 285, no. 42, pp. 32522–32528, 2010. View at Publisher · View at Google Scholar · View at Scopus
71. P. Y. Chiu, H. Y. Leung, M. K. T. Poon, D. H. F. Mak, and K. M. Ko, “Effects of schisandrin B enantiomers on cellular glutathione and menadione toxicity in AML12 hepatocytes,” Pharmacology, vol. 77, no. 2, pp. 63–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
72. Y. F. Wu, M. F. Cao, Y. P. Gao et al., “Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells,” World Journal of Gastroenterology, vol. 10, no. 20, pp. 2944–2948, 2004. View at Scopus
73. H. Ono, Y. Matsuzaki, Y. Wakui et al., “Determination of schizandrin in human plasma by gas chromatography-mass spectrometry,” Journal of Chromatography B, vol. 674, no. 2, pp. 293–297, 1995. View at Publisher · View at Google Scholar · View at Scopus
74. L. Volicer, M. Sramka, I. Janku, R. Capek, R. Smetana, and V. Ditteova, “Some pharmacological effects of Schizandra chinensis,” Archives Internationales de Pharmacodynamie et de Therapie, vol. 163, pp. 249–262, 1966.
75. H. M. Chang and P. P. H. But, Pharmacology of Oriental Plants. Singapore, Pergamon Press, Oxford, UK, 1965.
76. P. Y. Lam and K. M. Ko, “Beneficial effect of (–) Schisandrin B against 3-nitropropionic acid-induced cell death in PC12 cells,” BioFactors. In press. View at Publisher · View at Google Scholar
77. D. Blum-Degen, L. Frolich, S. Hoyer, and P. Riederer, “Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?” Journal of Neural Transmission, Supplement, no. 46, pp. 139–147, 1995. View at Scopus
78. T. Muller, “New small molecules for the treatment of Parkinson's disease,” Expert Opinion on Investigational Drugs, vol. 19, no. 9, pp. 1077–1086, 2010. View at Publisher · View at Google Scholar · View at Scopus
79. C. W. Olanow, O. Rascol, R. Hauser et al., “A double-blind, delayed-start trial of rasagiline in Parkinson's disease,” New England Journal of Medicine, vol. 361, no. 13, pp. 1268–1278, 2009. View at Publisher · View at Google Scholar · View at Scopus